PASADENA, Calif., Feb. 6, 2025 /PRNewswire/ -- Intuitive BioTechnologies LLC (IBT) is proud to announce they have added elemental analysis to their testing capabilities. IBT is now offering quantitative single or multi-element analysis as well as semi-quantitative screening. Using ICP-OES technology, IBT can quantify over 50 elements in a single measurement. Additionally, Agilent's IntelliQuant software provides semi-quantitative data of abundant commonly detected elements found in each sample, enabling rapid method development. This technology helps reduce client's cost and save valuable time and resources. With its new addition, IBT can measure many elements down to 10 ppb and can even measure samples with up to 5% total dissolved solids. With the ability to test over 1000 samples a day, IBTs elemental ...
We are thrilled to extend our heartfelt gratitude to CSL Behring for their generous donation of lab supplies, computer monitors and other office supplies. This valuable contribution not only supports the mission of Pasadena Bio Collaborative's educational training programs but also benefits local high schools and community colleges throughout Los Angeles County. CSL Behring's support helps us continue to provide hands-on training to the next generation of scientists, researchers and healthcare professionals. By equipping our facilities with the necessary tools, they empower students to gain practical experience and develop the skills they need to succeed in their future careers. We are deeply appreciative of CSL Behring's commitment to education and the positive impact it has on our community. Thank you, ...
Pasadena Bio Collaborative has recently acquired a new Bio-Rad CFX96 with C1000 RT-PCR Detection System. Continually updating our equipment is important to meeting current tenant needs, attracting new tenants, & providing training opportunities. "Poseidon is a pre-clinical stage start-up biotechnology company with a patented platform-technology to develop new biological therapeutics using an alternative protein modality. The latest addition to Pasadena Bio communal equipment is the BioRad RT- PCR machine. This machine will help us to validate our lead candidates for IND enabling studies with a well-defined assay. The assay has the capability to define the candidates with development potential, drastically shortening the candidate selection time and cost."- Rajika Perera, CEO This project was funded in part by a grant from ...
Serving as the only nonprofit biotechnology research lab in the greater Pasadena area, Pasadena BioScience Collaborative is a non-profit organization focused on educational and training opportunities for potential future employees in the sector. Its incubator facilities feature shared equipment and office space designed to support small start-up companies and develop a highly skilled workforce in the sciences. Even local high school students benefit from Pasadena Bio’s educational outreach and work force development programs thanks to its partnership with the Amgen Biotech Experience.  Bud Bishop, Pasadena Bio’s President, is grateful that PCF’s support will allow his facility to upgrade shared-use genetic sequencing equipment, which will benefit current and future researchers/tenants in developing cutting-edge biotech opportunities for the local community: “We are ...
Campbell Neurosciences Division Aims to Combat Suicide-Causing Brain Inflammation using Stromal Vascular Fraction Immunotherapy OCEANSIDE, Calif., Dec. 16, 2020 /PRNewswire/ -- Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today signing a letter of intent with Synova Life Sciences aimed at developing a "First in Class" cellular therapy for suicide and suicidal ideation. Under the proposed collaboration, Therapeutic Solutions International will contribute its existing expertise and intellectual property regarding adipose stem cell treatment of neuroinflammatory disorders, whereas Synova Life Sciences will provide access to its non-enzymatic stromal vascular fraction isolation device. The two parties aim to file an Investigational New Drug (IND) application to the FDA for initiating a clinical trial in patients at high risk of suicide. "Numerous publications ...